Concessions Mark Solvay Settlement

Law360, New York (September 14, 2006, 12:00 AM EDT) -- The U.S. pharmaceutical unit of Belgian chemicals firm Solvay SA has settled a pair of patent-infringement lawsuits with two generic drug makers over a treatment for low testosterone, or “Low T.”

The settlement puts to rest lawsuits filed in August 2003 against generic drug makers Watson Pharmaceuticals Inc. and a partner of Par Pharmaceutical Companies Inc. in the U.S. District Court for the Northern District of Georgia.

The lawsuits were filed by Marietta, Georgia-based Unimed Pharmaceuticals Inc.—a subsidiary of Solvay Pharmaceuticals Inc.—after both defendants filed Abbreviated...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.